Sage Therapeutics takes on major depressive disorder

In this video

Share

Sage Therapeutics takes on major depressive disorder

CNBC's Meg Tirrell speaks with Sage Therapeutics CEO Jeff Jonas about the company's depression drug, which showed results in a mid-stage drug trial.
04:37
Fri, Dec 8 20171:23 PM EST